English Overview
Dr. Lakshmanan will shed light on the role of GLP-1 RAs in the treatment of T2DM with a special focus on cardiovascular impact. Live lecture followed by Q&A.
This Activity for
- Resident / Fellow
- Physician
What I will learn?
By the end of the lecture the audience should be able to:
1. Understand the different GLP-1 RA CV trials and outcomes to be able select appropriate therapy for the right patient
2. Look beyond glycemic control when considering therapy for T2DM patients who have other disease related risks
1. Understand the different GLP-1 RA CV trials and outcomes to be able select appropriate therapy for the right patient
2. Look beyond glycemic control when considering therapy for T2DM patients who have other disease related risks
Speakers 1 Distinguished Speakers
Additional items to the activity
| Optional Details | Type | Fee |
|---|---|---|
|
Meet the Expert: GLP-1 RA and CV Risk Reduction in T2DM Certificate
Accreditation |
Certificate | Free |
VAT 15% Included
